Access Swiss Biotech Insight-IQVIA partnered - Access event recording 

From proof of concept to proof of value: demonstrating asset value is becoming more complex as the market evolves from volume- to value-based performance. To find out more and if you missed this Swiss Biotech Insight-IQVIA partnered event in Luzern on Sept 30th, you can access the video recording here:

👉🏻 Listen to recording here

How can biotech stakeholders define and build an actionable plan to maximize their asset value?
🔹 Is an integrated evidence generation plan a mandatory requirement to maximize asset value?
🔹 Is self-commercialization the best way to retain value?
🔹 Is omnichannel sales & marketing an imperative in the post-pandemic environment?

At the Swiss Biotech Insight event, organized by IQVIA together with the Swiss Biotech Association, expert panelists delivered an insightful panel-discussion on these key themes for biotech companies.


  • September 30, 2022 @ 12:00 am
  • December 30, 2022
  • Luzern
Event starts in
  • 00

  • 00

  • 00


Europaplatz 1, Luzern, Switzerland

Contact Form